🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07665333
Starting soon Not applicable

Multidisciplinary Health Monitoring for Esports Players

NCT07665333 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-09
Last updated
2026-06-24

Condition(s) studied

Musculoskeletal PainSedentary BehaviorDiet HabitPhysiological Stress

Investigational drug(s) / intervention(s)

Multidisciplinary Preventive Exercise Program

Multidisciplinary Preventive Exercise Program: A 12-week individualized program delivered 2 days per week, integrated into gameplay as a 5-minute exercise block during the 10-minute break following each 45-minute play session. Three components: (1) dynamic stretching and mobility (thoracic extension, hip swings, pectoralis dynamic stretches; 2 sets x 10 reps each); (2) strength and endurance (craniocervical flexion 2x15 with 10-sec holds, plank 3x15 sec, isometric wrist extension 3x45 sec at 30% MVIC, air squats 3x12); (3) vestibular and visual training (quiet eye training 2x15, letter-tracking, and sport-specific VOR training 3x20 sec each).

Study summary

This study aims to develop a holistic, multidisciplinary health monitoring/screening module that evaluates the health and performance parameters of esports players, and to apply and assess the effectiveness of an individualized multidisciplinary preventive intervention program (PIP) based on the screening findings. Esports players are frequently exposed to prolonged sitting, repetitive movements, high screen time, and irregular lifestyle habits, which can lead to musculoskeletal problems, visual strain, increased cardiovascular load, sleep disturbances, and psychological effects. Comprehensive, systematic, and multidisciplinary screening models addressing these risks remain limited in the literature.

Amateur and/or professional players from the Yeditepe University Esports Club will undergo a multidimensional baseline assessment covering cardiovascular and respiratory parameters, musculoskeletal analysis, visual strain, nutritional status, cognitive function, and mental status. Participants will then be allocated to a control group or an intervention group. The intervention group will complete a 12-week individualized preventive exercise protocol in addition to their usual training, while the control group continues their usual training routine. All measurements will be repeated after 12 weeks to evaluate the effectiveness of the program.

Eligibility

Sex
MALE
Min age
18 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Aged 18-35 years * Active esports player at university or professional level * Regularly engaged in esports training/play for at least the past 6 months (\>=3 days/week) * Cognitively able to understand and complete the tests and questionnaires * Average daily screen/gaming exposure of \>=3 hours * Willing to participate in the assessment and exercise program and providing written informed consent Exclusion Criteria: * Serious musculoskeletal injury or surgery within the past 6 months * Diagnosed neurological disease (e.g., epilepsy, MS, Parkinson's) * Cardiovascular or respiratory disease that contraindicates exercise * Diagnosed serious psychiatric disorder (e.g., major depression, bipolar disorder, psychotic disorders) or being in active treatment * Regular medication use at a level that could affect physiological or cognitive measurements * Any condition that would prevent regular participation throughout the study (e.g., time constraints, lack of motivation)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Yeditepe University Kozyatağı Hospital Istanbul Turkey (Türkiye)

More Yeditepe University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07665333 on ClinicalTrials.gov ↗ ← All trials in Turkey